Nuevolution: Data from BET-inhibitor in cancer models
Research Note
2019-02-21
14:57
Nuevolution today announced the first pre-clinical data in cancer models from their BET-BD1 inhibitor, which has so far been focused on fibrotic and dermatological diseases.
MS
Mathias Spinnars
Disclosures and disclaimers